Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -58.78x is 65% above its 4-year average of -166.16x, near the high end of its 4-year range (-478.80x–-7.39x).
43.28% above its 12-month average of -103.63x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -417.50x.
INTEREST COVERAGE RATIO
-58.78x
INTEREST COVERAGE RATIO AVG TTM
-103.63x
INTEREST COVERAGE RATIO AVG 3Y
-103.63x
INTEREST COVERAGE RATIO AVG 5Y
-166.16x
INTEREST COVERAGE RATIO AVG 10Y
-196.14x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+43.28%
CURRENT VS 3Y AVG
+43.28%
CURRENT VS 5Y AVG
+64.62%
CURRENT VS 10Y AVG
+70.03%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-2.74x
median of 289 covered companies
CURRENT VS SECTOR MEDIAN
-2045.26%
vs the sector median at left
Artelo Biosciences, Inc.
Market Cap
$1.36M
Interest Coverage Ratio
-58.78x
TTM Avg
-103.63x
3Y Avg
-103.63x
5Y Avg
-166.16x
Market Cap
$1.49M
Interest Coverage Ratio
-13.48x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14M
Interest Coverage Ratio
-7.46x
TTM Avg
10.39x
3Y Avg
21.90x
5Y Avg
21.90x
Market Cap
$1.11M
Interest Coverage Ratio
-290.08x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.02M
Interest Coverage Ratio
-2.27x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$888387.00
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$885939.00
Interest Coverage Ratio
N/A
TTM Avg
354.05x
3Y Avg
372.60x
5Y Avg
299.52x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Artelo Biosciences, Inc. (ARTL) | $1.36M | -58.78x | -103.63x | -103.63x | -166.16x |
| Genprex, Inc. (GNPX)vs › | $1.37M | -20.97x | N/A | N/A | N/A |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -13.48x | N/A | N/A | N/A |
| Curis, Inc. (CRIS)vs › | $1.54M | -15.06x | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -7.46x | 10.39x | 21.90x | 21.90x |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | -290.08x | N/A | N/A | N/A |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -2.27x | N/A | N/A | N/A |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | N/A | 354.05x | 372.60x | 299.52x |
| Bone Biologics Corporation (BBLG)vs › | $878396.00 | N/A | N/A | N/A | N/A |
Interest Coverage
-58.8x
Debt/Equity
0.01
Current Ratio
3.00
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -417.50x |
| 2026-03-31 | -21.69x |
| 2025-12-31 | -7.39x |
| 2025-09-30 | -27.83x |
| 2025-06-30 | -43.75x |
| 2022-09-30 | -478.80x |
| 2017-08-31 | -652.84x |
| 2017-05-31 | -103.70x |
| 2017-02-28 | -11.81x |
